MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,160,000 | -46.1% | 285,000 | -47.7% | 0.03% | -44.3% |
| Q2 2019 | $15,140,000 | -10.5% | 545,000 | +7.0% | 0.06% | -15.3% |
| Q1 2019 | $16,918,000 | +58.3% | 509,564 | +38.6% | 0.07% | +33.3% |
| Q4 2018 | $10,685,000 | -10.7% | 367,564 | +41.4% | 0.05% | +8.0% |
| Q3 2018 | $11,960,000 | +23.1% | 260,000 | 0.0% | 0.05% | +19.0% |
| Q2 2018 | $9,716,000 | +37.0% | 260,000 | +8.3% | 0.04% | +27.3% |
| Q1 2018 | $7,092,000 | +11.6% | 240,000 | +29.7% | 0.03% | +13.8% |
| Q4 2017 | $6,354,000 | -18.5% | 185,000 | -14.2% | 0.03% | -21.6% |
| Q3 2017 | $7,797,000 | +40.0% | 215,500 | 0.0% | 0.04% | +32.1% |
| Q2 2017 | $5,569,000 | +112.5% | 215,500 | +57.9% | 0.03% | +100.0% |
| Q1 2017 | $2,621,000 | +96.5% | 136,500 | +70.6% | 0.01% | +75.0% |
| Q4 2016 | $1,334,000 | +62.1% | 80,000 | +100.0% | 0.01% | +100.0% |
| Q3 2016 | $823,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |